Meta-analysis of the efficacy and safety of Ilaprazole Enteric-Coated Tablets on reflux esophagitis
10.12206/j.issn.2097-2024.202111080
- VernacularTitle:艾普拉唑肠溶片用于治疗反流性食管炎的有效性及安全性Meta分析
- Author:
Xiaoyun CHEN
1
;
Xu ZHAO
2
;
Weiwei ZENG
3
Author Information
1. Department of Pharmacy, Shantou Central Hospital, Shantou 515000，China;Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat - Sen University, Guangzhou 510080，China.
2. Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat - Sen University, Guangzhou 510080，China.
3. Department of Pharmacy, Shenzhen Baoan Women’s and Children’s Hospital, Shenzhen 518102，China.
- Keywords:
Reflux esophagitis;
Ilaprazole Enteric-Coated Tablets;
Meta-analysis
- From:
Journal of Pharmaceutical Practice
2023;41(7):443-448
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of Ilaprazole Enteric-Coated Tablets in the treatment of RE. Methods The databases of CNKI, VIP, Wanfang Data, PubMed, Embase, and The Cochrane Library were searched to collect all the randomized controlled trials (RCTs) of Ilaprazole in the treatment of RE published before April 2021. After data extraction and quality evaluation, the RCTs meeting the inclusion criteria were performed, and the meta-analysis was conducted by RevMan 5.4. Results Nine RCTs were included, with a total of 1115 patients of RE. The results of the meta-analysis showed that Ilaprazole Enteric-Coated Tablets were comparable to Esomeprazole Enteric-Coated Tablets in both endoscopic efficiency (90.08% vs. 90.00%, P > 0.05) and symptom relief rates (91.79% vs. 91.23%, P > 0.05), and there was no statistically significant difference in the incidence of adverse reactions (7.99% vs. 8.66%, P > 0.05). Conclusion Ilaprazole Enteric-Coated Tablets with lower doses were comparable to Esomeprazole Enteric-Coated Tablets which showed good efficacy and safety in the treatment of reflux esophagitis.
